RNS Number : 0064T
22 March 2021

AVEVA GROUP PLC ('AVEVA' or 'the Company')


Admission of Consideration Shares



AVEVA announces that in connection with the completion of the acquisition of OSIsoft, LLC announced on Friday, 19 March 2021 ('Completion'), admission of 13,655,570 ordinary shares of 3 5/9 pence each in the capital of the Company ('Ordinary Shares') to the premium listing segment of the Official List of the FCA and to trading on the London Stock Exchange's main market for listed securities occurred this morning at 8.00 a.m. (GMT).


In conformity with the FCA's Disclosure Guidance and Transparency Rules ('Rules'), AVEVA also notifies the market of the following:


As a result of Completion, the Company's share capital has increased to 301,152,120 Ordinary Shares with voting rights. None of the Ordinary Shares are held in treasury. Therefore, the total number of voting rights in the Company is now 301,152,120.


The above total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in the Company under the Rules.





AVEVA Group plc

Matt Springett (Head of Investor Relations)

Tel: +44 7789 818 684


FTI Consulting LLP

PR Adviser to AVEVA

Edward Bridges

Dwight Burden

Tel: +44 20 3727 1017


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.